The Africa Breast Cancer Screening (ABCS) study aims to address the critical gap in understanding the interrelationship between metabolic syndrome, the gut microbiome, and breast cancer risk, particularly among sub-Saharan African women.

The study also aims to create a group of participants who will undergo breast cancer screening. This group will be monitored over time to gather more detailed information and understand the long-term effects of breast cancer.

“We are expecting to recruit women aged 18 and above and screen them for the presence or absence of breast cancer, as well as examine the stage and type for those who have it. This study will aid in early detection for those affected, making treatment easier. We are conducting this study across the country, and we hope that many women will participate in the screening.

It is not a stigma but a means to identify and prevent progression, thereby increasing survival,” he said. “The study will help us understand the risk factors and provide insights for better risk assessment and management. It will also help us develop targeted interventions for individuals diagnosed with breast cancer, ultimately enhancing the health of African women,” he added.

The ABCS study, funded by the World Cancer Research Fund, is the first of its kind on the continent and has a four-year timeline. Speaking on behalf of the KNUST Vice-Chancellor, Dr. Augustina Angelina Sylverken, a Senior Lecturer at the Department of Theoretical and Applied Biology, described the inception meeting as a springboard for sustainable breast cancer screening and early detection efforts.

Dr. Sylverken also stated that “the findings will not only enhance breast cancer screening in Ghana but will also set a precedent for other African nations to follow.” She highlighted KNUST’s commitment to becoming a leading research-intensive institution. “At KNUST, we are deeply committed to driving innovation and scientific discovery that addresses pressing global and local challenges,” she added.